Lipopolysaccharide signaling in endothelial cells

Angus, 2001, Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care, Crit Care Med, 29, 1303, 10.1097/00003246-200107000-00002 Pinsky, 2004, Dysregulation of the immune response in severe sepsis, Am J Med Sci, 328, 220, 10.1097/00000441-200410000-00005 Medzhitov, 2001, Toll-like receptors and innate immunity, Nat Rev Immunol, 1, 135, 10.1038/35100529 Jaffe, 1987, Cell biology of endothelial cells, Hum Pathol, 18, 234, 10.1016/S0046-8177(87)80005-9 Grandel, 2003, Endothelial responses to bacterial toxins in sepsis, Crit Rev Immunol, 23, 267, 10.1615/CritRevImmunol.v23.i4.20 Volk, 2000, Endothelium function in sepsis, Inflamm Res, 49, 185, 10.1007/s000110050579 Salgado, 1994, Inflammatory mediators and their influence on haemostasis, Haemostasis, 24, 132 Sumpio, 2002, Cells in focus: endothelial cell, Int J Biochem Cell Biol, 34, 1508, 10.1016/S1357-2725(02)00075-4 Rongen, 1994, Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications, Neth J Med, 44, 26 Ruschitzka, 1999, A rationale for treatment of endothelial dysfunction in hypertension, J Hypertens Suppl, 17, S25 Morikawa, 2000, Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide, Infect Immun, 68, 6209, 10.1128/IAI.68.11.6209-6214.2000 Petros, 1991, Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock, Lancet, 338, 1557, 10.1016/0140-6736(91)92376-D Spohr, 2005, Role of endogenous nitric oxide in endotoxin-induced alteration of hypoxic pulmonary vasoconstriction in mice, Am J Physiol Heart Circ Physiol, 289, H823, 10.1152/ajpheart.00605.2004 Thiemermann, 1997, Nitric oxide and septic shock, Gen Pharmacol, 29, 159, 10.1016/S0306-3623(96)00410-7 Yuan, 2002, Protein kinase signaling in the modulation of microvascular permeability, Vascul Pharmacol, 39, 213, 10.1016/S1537-1891(03)00010-7 Bannerman, 1998, Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction, Infect Immun, 66, 1400, 10.1128/IAI.66.4.1400-1407.1998 Bannerman, 1998, Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins, J Biol Chem, 273, 35371, 10.1074/jbc.273.52.35371 Kubes, 2002, The complexities of leukocyte recruitment, Semin Immunol, 14, 65, 10.1006/smim.2001.0343 Ulbrich, 2003, Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease, Trends Pharmacol Sci, 24, 640, 10.1016/j.tips.2003.10.004 Lush, 2000, LPS tolerance in human endothelial cells: reduced PMN adhesion, E-selectin expression, and NF-kappaB mobilization, Am J Physiol Heart Circ Physiol, 278, H853, 10.1152/ajpheart.2000.278.3.H853 Boyle, 1998, Inhibition of nuclear factor-kappa B nuclear localization reduces human E-selectin expression and the systemic inflammatory response, Circulation, 98, II282 Collins, 1995, Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers, FASEB J, 9, 899, 10.1096/fasebj.9.10.7542214 Cummings, 1997, Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction, Am J Respir Crit Care Med, 156, 431, 10.1164/ajrccm.156.2.9509017 Matsukawa, 2002, Mice genetically lacking endothelial selectins are resistant to the lethality in septic peritonitis, Exp Mol Pathol, 72, 68, 10.1006/exmp.2001.2416 Wu, 1996, Role of endothelium in thrombosis and hemostasis, Annu Rev Med, 47, 315, 10.1146/annurev.med.47.1.315 Dahlback, 2005, The anticoagulant protein C pathway, FEBS Lett, 579, 3310, 10.1016/j.febslet.2005.03.001 Moore, 1987, Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro, J Clin Invest, 79, 124, 10.1172/JCI112772 Pawlinski, 2004, Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis, Crit Care Med, 32, S293, 10.1097/01.CCM.0000128445.95144.B8 Parry, 1995, Transcriptional regulation of tissue factor expression in human endothelial cells, Arterioscler Thromb Vasc Biol, 15, 612, 10.1161/01.ATV.15.5.612 Alexander, 2001, Bacterial lipopolysaccharides and innate immunity, J Endotoxin Res, 7, 167 Hack, 2001, The endothelium in sepsis: source of and a target for inflammation, Crit Care Med, 29, S21, 10.1097/00003246-200107001-00011 Slack, 2000, Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways, J Biol Chem, 275, 4670, 10.1074/jbc.275.7.4670 Tabeta, 2004, Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection, Proc Natl Acad Sci USA, 101, 3516, 10.1073/pnas.0400525101 Chuang, 2000, Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9, Eur Cytokine Netw, 11, 372 Chuang, 2001, Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells, Biochim Biophys Acta, 1518, 157, 10.1016/S0167-4781(00)00289-X Du, 2000, Three novel mammalian toll-like receptors: gene structure, expression, and evolution, Eur Cytokine Netw, 11, 362 Poltorak, 1998, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, 282, 2085, 10.1126/science.282.5396.2085 Darveau, 2004, Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4, Infect Immun, 72, 5041, 10.1128/IAI.72.9.5041-5051.2004 Schumann, 1990, Structure and function of lipopolysaccharide binding protein, Science, 249, 1429, 10.1126/science.2402637 Dunzendorfer, 2004, TLR4 is the signaling but not the lipopolysaccharide uptake receptor, J Immunol, 173, 1166, 10.4049/jimmunol.173.2.1166 da Silva Correia, 2001, Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2, J Biol Chem, 276, 21129, 10.1074/jbc.M009164200 Wright, 1995, CD14 and innate recognition of bacteria, J Immunol, 155, 6, 10.4049/jimmunol.155.1.6 Arditi, 1993, Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14, Infect Immun, 61, 3149, 10.1128/iai.61.8.3149-3156.1993 Bufler, 1995, Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants, Eur J Immunol, 25, 604, 10.1002/eji.1830250244 Jersmann, 2001, Synthesis and surface expression of CD14 by human endothelial cells, Infect Immun, 69, 479, 10.1128/IAI.69.1.479-485.2001 Pugin, 1993, Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14, Proc Natl Acad Sci USA, 90, 2744, 10.1073/pnas.90.7.2744 Nagai, 2002, Essential role of MD-2 in LPS responsiveness and TLR4 distribution, Nat Immunol, 3, 667, 10.1038/ni809 Visintin, 2003, Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction, J Biol Chem, 278, 48313, 10.1074/jbc.M306802200 Triantafilou, 2002, Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster, Trends Immunol, 23, 301, 10.1016/S1471-4906(02)02233-0 Triantafilou, 2001, A CD14-independent LPS receptor cluster, Nat Immunol, 2, 338, 10.1038/86342 Dunzendorfer, 2004, Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses, FASEB J, 18, 1117, 10.1096/fj.03-1263fje Hornef, 2002, Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells, J Exp Med, 195, 559, 10.1084/jem.20011788 Hornef, 2003, Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells, J Exp Med, 198, 1225, 10.1084/jem.20022194 Shnyra, 1995, Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro, Infect Immun, 63, 865, 10.1128/iai.63.3.865-873.1995 Latz, 2002, Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2–CD14 complex in a process that is distinct from the initiation of signal transduction, J Biol Chem, 277, 47834, 10.1074/jbc.M207873200 Triantafilou, 2002, Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation, J Cell Sci, 115, 2603, 10.1242/jcs.115.12.2603 Zhang, 2002, Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling, FEBS Lett, 532, 171, 10.1016/S0014-5793(02)03669-4 Lee, 2004, Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation, J Biol Chem, 279, 10564, 10.1074/jbc.M311564200 Akira, 2004, Toll-like receptor signalling, Nat Rev Immunol, 4, 499, 10.1038/nri1391 Takeda, 2004, TLR signaling pathways, Semin Immunol, 16, 3, 10.1016/j.smim.2003.10.003 Wesche, 1997, MyD88: an adapter that recruits IRAK to the IL-1 receptor complex, Immunity, 7, 837, 10.1016/S1074-7613(00)80402-1 O'Neill, 2003, Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors, J Endotoxin Res, 9, 55, 10.1177/09680519030090010701 Li, 2002, IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase, Proc Natl Acad Sci USA, 99, 5567, 10.1073/pnas.082100399 Fitzgerald, 2001, Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction, Nature, 413, 78, 10.1038/35092578 Yamamoto, 2002, Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4, Nature, 420, 324, 10.1038/nature01182 Bannerman, 2002, TIRAP mediates endotoxin-induced NF-kappaB activation and apoptosis in endothelial cells, Biochem Biophys Res Commun, 295, 157, 10.1016/S0006-291X(02)00638-1 Burns, 2003, Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4, J Exp Med, 197, 263, 10.1084/jem.20021790 Suzuki, 2002, Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4, Nature, 416, 750, 10.1038/nature736 Cao, 1996, TRAF6 is a signal transducer for interleukin-1, Nature, 383, 443, 10.1038/383443a0 Chung, 2002, All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction, J Cell Sci, 115, 679, 10.1242/jcs.115.4.679 Jiang, 2002, Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol, Mol Cell Biol, 22, 7158, 10.1128/MCB.22.20.7158-7167.2002 Shibuya, 1996, TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction, Science, 272, 1179, 10.1126/science.272.5265.1179 Takaesu, 2000, TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway, Mol Cell, 5, 649, 10.1016/S1097-2765(00)80244-0 Kishida, 2005, TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway, Genes Cells, 10, 447, 10.1111/j.1365-2443.2005.00852.x Cheung, 2004, TAB3, a new binding partner of the protein kinase TAK1, Biochem J, 378, 27, 10.1042/bj20031794 Deng, 2000, Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain, Cell, 103, 351, 10.1016/S0092-8674(00)00126-4 Yamin, 1997, The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation, J Biol Chem, 272, 21540, 10.1074/jbc.272.34.21540 Jensen, 2003, Ubiquitin activated tumor necrosis factor receptor associated factor-6 (TRAF6) is recycled via deubiquitination, FEBS Lett, 553, 190, 10.1016/S0014-5793(03)00998-0 Wang, 2001, TAK1 is a ubiquitin-dependent kinase of MKK and IKK, Nature, 412, 346, 10.1038/35085597 Ea, 2004, TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6, Proc Natl Acad Sci USA, 101, 15318, 10.1073/pnas.0404132101 Chen, 1995, Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin–proteasome pathway, Genes Dev, 9, 1586, 10.1101/gad.9.13.1586 Zen, 1998, Lipopolysaccharide-inducedNFkappaB activation in human endothelial cells involves degradation of IkappaBalpha but not IkappaBbeta, Exp Cell Res, 243, 425, 10.1006/excr.1998.4162 Asehnoune, 2005, Involvement of PKCalpha/beta in TLR4 and TLR2 dependent activation of NF-kappaB, Cell Signal, 17, 385, 10.1016/j.cellsig.2004.08.005 Dallot, 2005, A role for PKCzeta in the LPS-induced translocation NF-kappaB p65 subunit in cultured myometrial cells, Biochimie, 87, 513, 10.1016/j.biochi.2005.02.009 Wymann, 1998, Structure and function of phosphoinositide 3-kinases, Biochim Biophys Acta, 1436, 127, 10.1016/S0005-2760(98)00139-8 Franke, 1995, The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase, Cell, 81, 727, 10.1016/0092-8674(95)90534-0 Fruman, 1999, Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha, Science, 283, 393, 10.1126/science.283.5400.393 Ojaniemi, 2003, Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages, Eur J Immunol, 33, 597, 10.1002/eji.200323376 Li, 2003, Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells, Infect Immun, 71, 4414, 10.1128/IAI.71.8.4414-4420.2003 Wong, 2004, Lipopolysaccharide initiates a TRAF6-mediated endothelial survival signal, Blood, 103, 4520, 10.1182/blood-2003-06-2118 Vivarelli, 2004, RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation, J Exp Med, 200, 399, 10.1084/jem.20040446 McCarthy, 1998, RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase, J Biol Chem, 273, 16968, 10.1074/jbc.273.27.16968 Chin, 2002, Involvement of receptor-interacting protein 2 in innate and adaptive immune responses, Nature, 416, 190, 10.1038/416190a Lu, 2005, Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity, J Biol Chem, 280, 16278, 10.1074/jbc.M410114200 Huang, 2004, Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3, Nat Immunol, 5, 98, 10.1038/ni1014 Hull, 2002, Lipopolysaccharide signals an endothelial apoptosis pathway through TNF receptor-associated factor 6-mediated activation of c-Jun NH2-terminal kinase, J Immunol, 169, 2611, 10.4049/jimmunol.169.5.2611 Matsuzawa, 2005, ROS-dependent activation of the TRAF6–ASK1–p38 pathway is selectively required for TLR4-mediated innate immunity, Nat Immunol, 6, 587, 10.1038/ni1200 Dumitru, 2000, TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway, Cell, 103, 1071, 10.1016/S0092-8674(00)00210-5 Patriotis, 1994, Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase, Proc Natl Acad Sci USA, 91, 9755, 10.1073/pnas.91.21.9755 Guha, 2001, Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression, Blood, 98, 1429, 10.1182/blood.V98.5.1429 Matsuguchi, 2003, JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation, EMBO J, 22, 4455, 10.1093/emboj/cdg438 Arndt, 2004, Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-kinase and Syk-mediated pathways, J Biol Chem, 279, 10883, 10.1074/jbc.M309901200 Pollet, 2003, Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kappaB and c-Jun N-terminal kinase, Blood, 102, 1740, 10.1182/blood-2003-01-0288 Haimovitz-Friedman, 1997, Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation, J Exp Med, 186, 1831, 10.1084/jem.186.11.1831 Kawai, 1999, Unresponsiveness of MyD88-deficient mice to endotoxin, Immunity, 11, 115, 10.1016/S1074-7613(00)80086-2 Kawai, 2001, Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes, J Immunol, 167, 5887, 10.4049/jimmunol.167.10.5887 Hoshino, 2002, Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation, Int Immunol, 14, 1225, 10.1093/intimm/dxf089 Oshiumi, 2003, TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta, J Biol Chem, 278, 49751, 10.1074/jbc.M305820200 Yamamoto, 2003, TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway, Nat Immunol, 4, 1144, 10.1038/ni986 Yamamoto, 2003, Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway, Science, 301, 640, 10.1126/science.1087262 Kaiser, 2005, Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif, J Immunol, 174, 4942, 10.4049/jimmunol.174.8.4942 Fitzgerald, 2003, IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway, Nat Immunol, 4, 491, 10.1038/ni921 Taniguchi, 2001, IRF family of transcription factors as regulators of host defense, Annu Rev Immunol, 19, 623, 10.1146/annurev.immunol.19.1.623 Sasai, 2005, Cutting edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation, J Immunol, 174, 27, 10.4049/jimmunol.174.1.27 Lentschat, 2005, Mastoparan, a G protein agonist peptide, differentially modulates TLR4- and TLR2-mediated signaling in human endothelial cells and murine macrophages, J Immunol, 174, 4252, 10.4049/jimmunol.174.7.4252 Grimm, 2001, Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation, J Cell Biol, 154, 345, 10.1083/jcb.200102032 Yamanashi, 1997, Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok, Cell, 88, 205, 10.1016/S0092-8674(00)81841-3 Di Cristofano, 1998, Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins, J Biol Chem, 273, 4827, 10.1074/jbc.273.9.4827 Lemay, 2000, Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling, Mol Cell Biol, 20, 2743, 10.1128/MCB.20.8.2743-2754.2000 Shinohara, 2005, Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling, J Exp Med, 201, 333, 10.1084/jem.20041817 Bedirian, 2004, Pleckstrin homology and phosphotyrosine-binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells, J Biol Chem, 279, 19335, 10.1074/jbc.M310689200 Itoh, 2005, Mitochondrial Dok-4 recruits Src kinase and regulates NF-{kappa}B activation in endothelial cells, J Biol Chem, 280, 26383, 10.1074/jbc.M410262200 Pahan, 1999, Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells, J Biol Chem, 274, 7528, 10.1074/jbc.274.11.7528 Martin, 2003, Role of the phosphatidylinositol 3 kinase–Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide, J Immunol, 171, 717, 10.4049/jimmunol.171.2.717 Schabbauer, 2004, PI3K–Akt pathway suppresses coagulation and inflammation in endotoxemic mice, Arterioscler Thromb Vasc Biol, 24, 1963, 10.1161/01.ATV.0000143096.15099.ce Fukao, 2002, PI3K-mediated negative feedback regulation of IL-12 production in DCs, Nat Immunol, 3, 875, 10.1038/ni825 Guha, 2002, The phosphatidylinositol 3-kinase–Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells, J Biol Chem, 277, 32124, 10.1074/jbc.M203298200 Pahan, 2000, Expression of a constitutively active form of phosphatidylinositol 3-kinase inhibits the induction of nitric oxide synthase in human astrocytes, FEBS Lett, 472, 203, 10.1016/S0014-5793(00)01465-4 Strassheim, 2004, Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils, J Immunol, 172, 5727, 10.4049/jimmunol.172.9.5727 Aksoy, 2005, Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappaB activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4, Eur J Immunol, 35, 2200, 10.1002/eji.200425801 Opipari, 1992, The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity, J Biol Chem, 267, 12424, 10.1016/S0021-9258(18)42292-2 Wertz, 2004, De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling, Nature, 430, 694, 10.1038/nature02794 Evans, 2004, Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity, Biochem J, 378, 727, 10.1042/bj20031377 Hu, 1998, Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells, Blood, 92, 2759, 10.1182/blood.V92.8.2759 Lee, 2000, Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice, Science, 289, 2350, 10.1126/science.289.5488.2350 O'Reilly, 2003, Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein, Biochem Biophys Res Commun, 303, 586, 10.1016/S0006-291X(03)00389-9 Boone, 2004, The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses, Nat Immunol, 5, 1052, 10.1038/ni1110 Chuang, 1998, A1 is a constitutive and inducible Bcl-2 homologue in mature human neutrophils, Biochem Biophys Res Commun, 249, 361, 10.1006/bbrc.1998.9155 Stroka, 1999, Overexpression of A1, an NF-kappaB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activation, Blood, 93, 3803, 10.1182/blood.V93.11.3803 Rocha, 2001, The BH4 domain of A1, an anti-apoptotic bcl family gene, is necessary and sufficient for its antiinflammatory function in endothelial cells, Transplant Proc, 33, 314, 10.1016/S0041-1345(00)02023-6 Chinnaiyan, 1995, FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis, Cell, 81, 505, 10.1016/0092-8674(95)90071-3 Choi, 1998, Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway, J Biol Chem, 273, 20185, 10.1074/jbc.273.32.20185 Bannerman, 2002, The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta, J Clin Invest, 109, 419, 10.1172/JCI0214774 Aliprantis, 2000, The apoptotic signaling pathway activated by Toll-like receptor-2, EMBO J, 19, 3325, 10.1093/emboj/19.13.3325 Burns, 2000, Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor, Nat Cell Biol, 2, 346, 10.1038/35014038 Zhang, 2002, Negative regulation of toll-like receptor-mediated signaling by Tollip, J Biol Chem, 277, 7059, 10.1074/jbc.M109537200 Bulut, 2001, J Immunol, 167, 987, 10.4049/jimmunol.167.2.987 Lioubin, 1996, p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity, Genes Dev, 10, 1084, 10.1101/gad.10.9.1084 Sly, 2004, LPS-induced upregulation of SHIP is essential for endotoxin tolerance, Immunity, 21, 227, 10.1016/j.immuni.2004.07.010 An, 2005, Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism, Blood, 105, 4685, 10.1182/blood-2005-01-0191 Zippo, 2004, Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro, Blood, 103, 4536, 10.1182/blood-2003-11-3827 Moritz, 1998, The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors, J Immunol, 161, 4866, 10.4049/jimmunol.161.9.4866 Xu, 1998, Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells, J Exp Med, 187, 787, 10.1084/jem.187.5.787 Brint, 2004, ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance, Nat Immunol, 5, 373, 10.1038/ni1050 Liew, 2005, A novel negative regulator for IL-1 receptor and Toll-like receptor 4, Immunol Lett, 96, 27, 10.1016/j.imlet.2004.07.008 Kumar, 1995, ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1, J Biol Chem, 270, 27905, 10.1074/jbc.270.46.27905 Yoshimura, 2005, Negative regulation of cytokine signaling and immune responses by SOCS proteins, Arthritis Res Ther, 7, 100, 10.1186/ar1741 Nakagawa, 2002, SOCS-1 participates in negative regulation of LPS responses, Immunity, 17, 677, 10.1016/S1074-7613(02)00449-1 Kinjyo, 2002, SOCS1/JAB is a negative regulator of LPS-induced macrophage activation, Immunity, 17, 583, 10.1016/S1074-7613(02)00446-6 Wang, 2003, Fetal plasma stimulates endothelial cell production of cytokines and the family of suppressor of cytokine signaling in umbilical placental vascular disease, Am J Obstet Gynecol, 188, 510, 10.1067/mob.2003.152 Divanovic, 2005, Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105, Nat Immunol, 6, 571, 10.1038/ni1198 Miyake, 1998, Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression, J Immunol, 161, 1348, 10.4049/jimmunol.161.3.1348 Hijiya, 2002, Possible involvement of toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide, Pathobiology, 70, 18, 10.1159/000066000 Kishore, 2005, Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4, FEBS Lett, 579, 699, 10.1016/j.febslet.2004.12.047 Murdoch, 1999, Cxc chemokine receptor expression on human endothelial cells, Cytokine, 11, 704, 10.1006/cyto.1998.0465 Wald, 2003, SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling, Nat Immunol, 4, 920, 10.1038/ni968 Qin, 2005, SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms, J Biol Chem, 280, 25233, 10.1074/jbc.M501363200 Chuang, 2004, Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors, Nat Immunol, 5, 495, 10.1038/ni1066 Janssens, 2002, Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88, Curr Biol, 12, 467, 10.1016/S0960-9822(02)00712-1 Janssens, 2003, MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression, FEBS Lett, 548, 103, 10.1016/S0014-5793(03)00747-6 Wesche, 1999, IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family, J Biol Chem, 274, 19403, 10.1074/jbc.274.27.19403 Kobayashi, 2002, IRAK-M is a negative regulator of Toll-like receptor signaling, Cell, 110, 191, 10.1016/S0092-8674(02)00827-9 Fritz, 2005, Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists, Eur J Immunol, 35, 2459, 10.1002/eji.200526286 Naiki, 2005, Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling, J Biol Chem, 280, 5491, 10.1074/jbc.C400503200